Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Maravai Lifesciences Holdings (MRVI) Asset Utilization Ratio: 2021-2025

Historic Asset Utilization Ratio for Maravai Lifesciences Holdings (MRVI) over the last 5 years, with Sep 2025 value amounting to 0.22.

  • Maravai Lifesciences Holdings' Asset Utilization Ratio rose 8.39% to 0.22 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.22, marking a year-over-year increase of 8.39%. This contributed to the annual value of 0.21 for FY2024, which is 35.49% up from last year.
  • Maravai Lifesciences Holdings' Asset Utilization Ratio amounted to 0.22 in Q3 2025, which was down 6.92% from 0.24 recorded in Q2 2025.
  • Over the past 5 years, Maravai Lifesciences Holdings' Asset Utilization Ratio peaked at 0.45 during Q1 2022, and registered a low of 0.15 during Q4 2023.
  • In the last 3 years, Maravai Lifesciences Holdings' Asset Utilization Ratio had a median value of 0.22 in 2025 and averaged 0.22.
  • Per our database at Business Quant, Maravai Lifesciences Holdings' Asset Utilization Ratio soared by 55.43% in 2022 and then slumped by 60.51% in 2023.
  • Quarterly analysis of 5 years shows Maravai Lifesciences Holdings' Asset Utilization Ratio stood at 0.42 in 2021, then decreased by 7.03% to 0.39 in 2022, then tumbled by 60.51% to 0.15 in 2023, then soared by 47.31% to 0.23 in 2024, then grew by 8.39% to 0.22 in 2025.
  • Its Asset Utilization Ratio was 0.22 in Q3 2025, compared to 0.24 in Q2 2025 and 0.25 in Q1 2025.